Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Wharton

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Science Translational Medicine|October 27, 2017
Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patientsEvangelos D Michelakis, Vikram Gurtu, Linda Webster, et al.
American Journal of Respiratory and Critical Care Medicine|April 8, 2022
Mining the Plasma Proteome for Insights into the Molecular Pathology of Pulmonary Arterial HypertensionLars Harbaum, Christopher J Rhodes, John Wharton, et al.
Circulation|November 25, 2016
Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial HypertensionChristopher J Rhodes, Pavandeep Ghataorhe, John Wharton, et al.
Nature Communications|January 6, 2024
Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertensionAnna Ulrich, Yukyee Wu, Harmen Draisma, et al.
JCI Insight|January 11, 2019
Human PAH is characterized by a pattern of lipid-related insulin resistanceAnna R Hemnes, J Matthew Luther, Christopher J Rhodes, et al.
Annals of the American Thoracic Society|March 18, 2021
Supplementation with Iron in Pulmonary Arterial Hypertension. Two Randomized Crossover TrialsLuke S G E Howard, Jianguo He, Geoffrey M J Watson, et al.
The European Respiratory Journal|January 19, 2019
The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertensionMichael Newnham, Kieron South, Marta Bleda, et al.
American Journal of Respiratory and Critical Care Medicine|May 1, 2020
Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical OutcomeChristopher J Rhodes, Pablo Otero-Núñez, John Wharton, et al.
The European Respiratory Journal|March 30, 2019
Traffic exposures, air pollution and outcomes in pulmonary arterial hypertension: a UK cohort study analysisEleni Sofianopoulou, Stephen Kaptoge, Stefan Gräf, et al.
Nature Communications|December 8, 2021
Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole bloodSokratis Kariotis, Emmanuel Jammeh, Emilia M Swietlik, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Science Translational Medicine|October 27, 2017
Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patientsEvangelos D Michelakis, Vikram Gurtu, Linda Webster, et al.
American Journal of Respiratory and Critical Care Medicine|April 8, 2022
Mining the Plasma Proteome for Insights into the Molecular Pathology of Pulmonary Arterial HypertensionLars Harbaum, Christopher J Rhodes, John Wharton, et al.
Circulation|November 25, 2016
Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial HypertensionChristopher J Rhodes, Pavandeep Ghataorhe, John Wharton, et al.
Nature Communications|January 6, 2024
Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertensionAnna Ulrich, Yukyee Wu, Harmen Draisma, et al.
JCI Insight|January 11, 2019
Human PAH is characterized by a pattern of lipid-related insulin resistanceAnna R Hemnes, J Matthew Luther, Christopher J Rhodes, et al.
Annals of the American Thoracic Society|March 18, 2021
Supplementation with Iron in Pulmonary Arterial Hypertension. Two Randomized Crossover TrialsLuke S G E Howard, Jianguo He, Geoffrey M J Watson, et al.
The European Respiratory Journal|January 19, 2019
The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertensionMichael Newnham, Kieron South, Marta Bleda, et al.
American Journal of Respiratory and Critical Care Medicine|May 1, 2020
Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical OutcomeChristopher J Rhodes, Pablo Otero-Núñez, John Wharton, et al.
The European Respiratory Journal|March 30, 2019
Traffic exposures, air pollution and outcomes in pulmonary arterial hypertension: a UK cohort study analysisEleni Sofianopoulou, Stephen Kaptoge, Stefan Gräf, et al.
Nature Communications|December 8, 2021
Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole bloodSokratis Kariotis, Emmanuel Jammeh, Emilia M Swietlik, et al.
Pageof 7